FDA Inspection 762942 — Mediagnost GmbH

Mediagnost GmbH — FEI 3003283395

The FDA completed an inspection of Mediagnost GmbH on January 11, 2012 in Reutlingen. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 11, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Reutlingen (Germany)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
311821 CFR 820.75(a)Documentation
313221 CFR 820.120Lack of or inadequate procedures for labeling
315921 CFR 820.184DHR content
368321 CFR 820.70(g)Equipment Installation, Placement, Specified Requirements
50221 CFR 820.60Identification procedures, Lack of or inadequate procedures
63021 CFR 803.17Lack of Written MDR Procedures